Chicago Ridge, ILNCT07005154Now EnrollingIRB Ready

Prostate Cancer Clinical Trial in Chicago Ridge, IL

Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Chicago Ridge. Study-provided care at no cost to qualified participants.

Sponsored by Astellas Pharma Global Development, Inc.

Quick Self-Assessment

See if you qualify for this Chicago Ridge location

Preparing your pre-screening questions...

Expert Care in Chicago Ridge

Access prostate cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related prostate cancer treatment provided free

Apply for This Chicago Ridge Location

Check if you qualify for this prostate cancer clinical trial in Chicago Ridge, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago Ridge

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago Ridge site if eligible
  4. 4Begin participation

About This Prostate Cancer Study in Chicago Ridge

Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen receptor pathway inhibitors (ARPIs) are another type of hormone therapy. They either slow down how much testosterone is made or block testosterone from reaching the prostate cancer cells. Abiraterone acetate (AA) is an ARPI that is used to treat advanced prostate cancer. This type of treatment is usuall

Sponsor: Astellas Pharma Global Development, Inc.

Who Can Participate

Inclusion Criteria

Participant is diagnosed with histologically or cytologically confirmed adenocarcinoma of the prostate without neuroendocrine differentiation or small cell features.
Participant has ECOG performance status of 0 or 1, or ECOG performance status of 2 if due to bone pain.
Participant with mHSPC must have an estimated life expectancy of ≥ 12 months or \> 6 months if participant has mCRPC.
Participant is able to understand and comply with all study requirements and procedures, including completion of PRO questionnaires.
Male participant must agree to use defined forms of contraception with female partner(s) of childbearing potential (including breastfeeding partner) throughout the treatment period and for 7 months after final ASP5541 or for 3 months after AA study intervention administration.
Male participant must agree to remain abstinent or use a condom with pregnant partner(s) for the duration of the pregnancy throughout the investigational period and for

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago Ridge?

Yes, this clinical trial (NCT07005154) has an active research site in Chicago Ridge, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Prostate Cancer Treatment Options in Chicago Ridge, IL

If you're searching for prostate cancer treatment options in Chicago Ridge, IL, this clinical trial (NCT07005154) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago Ridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all prostate cancer clinical trials near you to find additional studies recruiting in your area.

More Prostate Cancer Trials in Chicago Ridge, IL

See all prostate cancer clinical trials recruiting in Chicago Ridge — not just this study.

Browse Prostate Cancer Trials in Chicago Ridge →

Browse More Trials by Condition

Prostate Cancer TrialsAll Conditions →

Ready to Join in Chicago Ridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago Ridge, IL